'Cancer is an increasingly important health issue in the APAC region’
Drug Discovery | Influencers | By Aishwarya venkatesh | 1 Comment | 09 Mar, 2018
Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new repo...Read more
USFDA approves Taiwan's HIV drug
Drug Discovery | News | 0 Comment | 08 Mar, 2018
A biologically-based alternative HIV treatment developed in Taiwan and manufactured in China has won approval from the U...Read more
FDA approves Prometic’s inter-alpha-inhibitor-proteins
Drug Discovery | News | 0 Comment | 06 Mar, 2018
Singapore- Prometic Life Sciences Inc. announced that the U.S Food and Drug Administration (FDA) has granted a Rar...Read more
Novo Nordisk’s diabetes pill presents the first successful data
Drug Discovery | News | 0 Comment | 26 Feb, 2018
Novo Nordisk, the world’s largest diabetes drugmaker has presented the first successful data from a large final-st...Read more
STA Pharma, Regulus team up for mRNA targeting drugs
Drug Discovery | News | 0 Comment | 23 Feb, 2018
A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...Read more
Asia needs a legal framework to combat rare diseases
Drug Discovery | Analysis | By Aishwarya Venkatesh | 1 Comment | 08 Feb, 2018
Orphan diseases, once rare, are now affecting larger populations, with one in every 5000 people suffering from a rare ge...Read more
DL Medicine teams up with Pfizer for new drug discovery
Drug Discovery | News | 0 Comment | 07 Feb, 2018
China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer I...Read more
New study shows baldness and prostate cancer may be interrelated
Drug Discovery | News | 1 Comment | 25 Jan, 2018
Singapore - A recent study observed a connection between male-pattern baldness, when it occurs at a young age, and the s...Read more
Drug Discovery | News | 0 Comment | 24 Jan, 2018
Computation-driven pharmaceutical technology company XtalPi Inc. has closed a Series B funding round of $15 million led ...Read more
OBI Pharma receives FDA nod for Phase I study of its cancer drug
Drug Discovery | News | 0 Comment | 18 Jan, 2018
Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug ...Read more
Forty Seven collaborates with Merck KGaA on a novel combination for ovarian cancer
Drug Discovery | News | 0 Comment | 16 Jan, 2018
Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational...Read more
FDA approves first treatment for breast cancer with a certain inherited genetic mutation
Drug Discovery | News | 0 Comment | 15 Jan, 2018
Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include th...Read more
Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives
Drug Discovery | News | 0 Comment | 15 Jan, 2018
Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...Read more
BerGenBio meets first efficacy endpoint in phase II trial evaluating BGB324
Drug Discovery | News | 0 Comment | 10 Jan, 2018
A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been ...Read more
Intec Pharma acknowledged with patent
Drug Discovery | Regulatory | 0 Comment | 08 Jan, 2018
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordio...Read more
Pfizer to launch a new venture fund to invest in neuroscience research projects
Drug Discovery | News | 0 Comment | 08 Jan, 2018
The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating...Read more
Drug for diabetes type 2 shows potential in treating Alzheimer’s
Drug Discovery | News | 0 Comment | 04 Jan, 2018
According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly b...Read more
Biocon & Mylan's biosimilar gets Brazilian approval
Drug Discovery | News | 0 Comment | 29 Dec, 2017
The biosimilar trastuzumab has been approved by ANVISA, the Brazilian regulatory agency. Co-developed by Biocon and...Read more